AWS Summit: A Peek at the ‘One FDA’ Plan to Modernize Tech Procurement
Acquisition leader Joseph Montgomery shares how AI and cloud technologies informed the agency’s new strategy.
The Food and Drug Administration recently released a new acquisition strategy that aims to transform how the agency buys technology to impact multiple mission areas. In an interview with FDA Office of Enterprise Portfolio Management Director Joseph Montgomery at AWS Summit, he highlights the importance of this strategy to create a “one FDA” ecosystem that prioritizes advanced technology and keeping pace with IT innovation.
Montgomery also highlights how he’s thinking about artificial intelligence, cybersecurity and cloud to impact financial operations (FinOps) and ultimately support FDA’s modernization goals.
Check out our full conference coverage.
This is a carousel with manually rotating slides. Use Next and Previous buttons to navigate or jump to a slide with the slide dots
-
Biden's Technology Legacy: Advancing AI, Cybersecurity
Executive orders, memos and policy all strengthened information technology policy in the outgoing administration.
6m read -
AI Startups Help Detect, Prevent Common Cancers in Women
Brittany Connors, SBIR director of investor relations at NCI, discussed how she is working with startups to develop the technology that better detects breast cancer and cervical cancer in their early stages.
23m listen -
Opinion: Effective AI Hinges on Meaningful Strategic Vision
AI’s transformative power lies in redefining work, augmenting human potential and driving sustainable, strategic advantage.
10m read -
How Emerging Tech Removes Burdens at Nation’s Borders for CBP Officers
CBP Acting Executive Assistant Commissioner Diane Sabatino discussed her vision for emerging technologies the agency is adopting at the nation’s ports.
23m listen
